Kazuko Matsuda
Chief Tech/Sci/R&D Officer at MEDICINOVA, INC.
Net worth: 426 355 $ as of 2024-04-29
Network origin in Kazuko Matsuda first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 28 | |
Keck School of Medicine of USC
 Keck School of Medicine of USC Other Consumer ServicesConsumer Services The Keck School of Medicine of USC is a place of dynamic activity in patient care, scientific discovery, medical and bioscience education, and community service. Their faculty, staff, students, residents, alumni, donors and friends are committed to excellence. Together they are poised to lead medicine in the 21st Century for the benefit of humankind. This is an exciting time of great transformation as they endeavor to create a truly stellar academic medical center at USC.
1
| College/University | Other Consumer Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Kazuko Matsuda via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMCOL INTERNATIONAL CORPORATION | Construction Materials | Chairman Director/Board Member | |
| BIOMERICA, INC. | Medical Specialties | Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Avigen, Inc.
 Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | Medical Specialties | Founder Corporate Officer/Principal Chief Executive Officer | |
| AVAX TECHNOLOGIES, INC. | Biotechnology | Chief Executive Officer | |
| PALATIN TECHNOLOGIES, INC. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
UBS Securities LLC
 UBS Securities LLC Investment ManagersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Investment Managers | Corporate Officer/Principal | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Director/Board Member | |
Elusys Therapeutics, Inc.
 Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Pharmaceuticals: Major | Director/Board Member Founder | |
Almirall LLC
 Almirall LLC Pharmaceuticals: MajorHealth Technology Almirall LLC manufactures and distributes pharmaceutical products. Its products include tablets, gel, ointment, lotion, and topical cream. The company was founded by Jay Gooding and Craig Ballaron in 2004 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ladenburg Thalmann & Co., Inc. (Broker)
 Ladenburg Thalmann & Co., Inc. (Broker) Investment Banks/BrokersFinance Ladenburg Thalmann & Co., Inc. (Broker) is the broker/dealer division of Ladenburg Thalmann & Co., Inc., ultimately held by Advisor Group Holdings, Inc. Headquartered in New York City, the firm was founded in 1876 and offers a full suite of capital markets products and services, including proprietary equity research and a fixed-income trading desk. For institutional asset management clients, the firm provides liquidity, execution, high-quality idea-generating research, and access to corporate management teams. Their institutional coverage includes relationships with over asset management companies all over the world. To corporate clients, they bring access to investor capital, broad distribution capabilities and financial markets advisory. Ladenburg Thalmann is a leader in financing growing middle-market public companies across various industry verticals, including Healthcare & Life Sciences, Yield-Oriented Securities (BDCs, REITs, MLPs), Energy, Power & Infrastructure, and Telecom, Media & Technology. | Investment Banks/Brokers | Analyst-Equity | |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Doctorate Degree | |
| CHUGAI PHARMACEUTICAL CO., LTD | Pharmaceuticals: Major | Director/Board Member | |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| University of Arizona | College/University | Undergraduate Degree Undergraduate Degree | |
| San Diego State University | College/University | Graduate Degree Undergraduate Degree | |
| University of Tokyo | College/University | Graduate Degree Undergraduate Degree | |
Antyra, Inc.
 Antyra, Inc. Pharmaceuticals: MajorHealth Technology Antyra, Inc. develops cancer therapeutics. Its products include lead programs, a program to generate and develop disease-specific therapeutics; oncology leads, such as IGF-1R Antagonist, which represent a clinical strategy for the treatment of pancreatic and other cancers; and ANT-G12, a technology that isolates cytotoxic peptimetics that bind to cell surface targets expressed in a disease-specific context. The company was founded by by John K. A. Prendergast and Arthur J. Blume in 1996 and is headquartered in Edison, NJ. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| RECCE PHARMACEUTICALS LTD | Pharmaceuticals: Major | Chairman Director/Board Member | |
| State University of New York at Buffalo | College/University | Undergraduate Degree Doctorate Degree | |
| Haas School of Business | College/University | Undergraduate Degree | |
| Momoyama Gakuin University | College/University | Undergraduate Degree | |
Nippon Roche KK
 Nippon Roche KK Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Nippon Roche KK is a Japanese company that manufactures and sells pharmaceuticals. The company is based in Tokyo, Japan. Nippon Roche KK was acquired by Chugai Pharmaceutical Co., Ltd. from Roche Holding AG on October 01, 2002 for $1,613.74 million. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Delaware | College/University | Undergraduate Degree | |
| Vanderbilt Law School | College/University | Graduate Degree | |
| Vanderbilt Owen Graduate School of Management | College/University | Masters Business Admin | |
| University of California Irvine School of Medicine | College/University | Corporate Officer/Principal | |
| Otaru University of Commerce | College/University | Undergraduate Degree | |
TY Consulting Co., Ltd.
 TY Consulting Co., Ltd. Investment ManagersFinance Part of Toyo Horwath, TY Consulting Co., Ltd. is a consulting company based in Tokyo, Japan. The Japanese company aims to support corporate growth and development through new proposals and actions that add enthusiasm to knowledge and experience. Tatsuo Izumi has been the CEO of the company since 2007. | Investment Managers | Chief Executive Officer | |
| First Ocean View Corp. | Chief Executive Officer | ||
| HISTOGEN INC. | Biotechnology | Director/Board Member | |
| GUIDEWIRE SOFTWARE, INC. | Information Technology Services | Director of Finance/CFO | |
| Rutgers Business School | College/University | Masters Business Admin | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| NEOVACS | Pharmaceuticals: Major | Director/Board Member | |
| MUSC Foundation for Research Development | Director/Board Member | ||
| Clearview Projects, Inc. | Chief Executive Officer | ||
| DIMENSION THERAPEUTICS INC | Biotechnology | Director/Board Member |
Statistics
International
| United States | 39 |
| Japan | 7 |
| Australia | 2 |
| France | 2 |
Sectoral
| Health Technology | 21 |
| Consumer Services | 14 |
| Finance | 5 |
| Commercial Services | 3 |
| Non-Energy Minerals | 2 |
Operational
| Director/Board Member | 108 |
| Corporate Officer/Principal | 61 |
| Independent Dir/Board Member | 44 |
| Director of Finance/CFO | 42 |
| Undergraduate Degree | 26 |
Most connected contacts
| Insiders | |
|---|---|
| Alan Dunton | 34 |
| Arlene Morris | 28 |
| Jeff Himawan | 24 |
| David Crean | 23 |
| John Prendergast | 16 |
| Shintaro Asako | 15 |
| David O'Toole | 14 |
| Michael J. Gennaro | 14 |
| Esther van den Boom | 12 |
| Michael Denis Coffee | 11 |
| Carolyn Beaver | 11 |
| Hideki Nagao | 8 |
| Douglas Paulin | 8 |
| Geoffrey O'Brien | 8 |
| Yuichi Iwaki | 8 |
- Stock Market
- Insiders
- Kazuko Matsuda
- Company connections
